Studiu experimental — Studii Medicale 2026
114 studii găsite
24
mai
2026
Atherosclerosis Studiu experimental Expert
👤 Zhang XY, Jiang XT, Gisterå A, Ding Y, Basbous L … | PMID: 42177120
Studiu multicentric (endarterectomie umană, modele murine Ldlr-/-, culturi in vitro): receptorul NOD1 este exprimat în SMC vasculare NOD1+ din plăcile aterosclerotice, mai ridicat la pacienți simptomatici. Activarea NOD…
13
mai
2026
Circ Res Studiu experimental Cross-sect.
👤 Ibikunle CO, Garcia EJ, Xue C, Kim E, Yan H et al. | PMID: 42125810
Circ Res 2026: single-cell multiomics (CITE-seq + bulk RNA-seq) in placi aterosclerotice murine cu trasare linie VSMC. BHLHE40 — factor transcriptie candidat in tranzitia VSMC → celule spumoase (expresie crescuta, knock…
13
mai
2026
Dev Cell Studiu experimental Cross-sect.
👤 Yang Z, Zhu S, Lyu CA, Fu H, Chen W et al. | PMID: 41806831
Dev Cell 2026: BAF60C (remodelare cromatina SWI/SNF) redus in celule beta T2D. Mecanism: BAF60C-NPM1-Reg3b mRNA complex → stabilitate ARNm Reg3b → REG3B suprime macrofage insulare. Deletie BAF60C → agrava hiperglicemie,…
Peste 13000 de cabinete medicale își prezintă serviciile pe ROmedic.
12
mai
2026
Immunity Studiu experimental Cross-sect.
👤 Lu M, Han R, Yang H, Yang L, Zhao Q et al. | PMID: 41713421
Immunity 2026: multi-omics DC splenice umane — identificare DC2hm (cDC2 cu maturare homeostatică): upregulare auto-antigeni tisulari, mașinărie Treg, receptor TSLP. DC2hm induce Treg FOXP3+ din T naive. TSLP reproduce f…
10
mai
2026
J Ethnopharmacol Studiu experimental Cross-sect.
👤 et al. | PMID: 41692111
J Ethnopharmacol 2026: Decoctul Taohong Siwu (MTC) atenueaza sepsisul experimental (LPS) prin suprimarea polarizarii M1 (TNF-a, IL-6, NF-kB) si promovarea M2 (IL-10, Arg1, JAK2/STAT3). Leziuni pulmonare acute ameliorate…
10
mai
2026
J Control Release Studiu experimental Cross-sect.
👤 et al. | PMID: 41839263
J Control Release 2026: Nanoparticule ROS-responsive (Molecular Latch) cu baicalina+peptida de targeting pentru ateroscleroza. Eliberare selectiva la H2O2 din placa. In vitro: reducere TNF-a, IL-6, VCAM-1. In vivo ApoE-…
10
mai
2026
J Ethnopharmacol Studiu experimental Cross-sect.
👤 et al. | PMID: 41655726
J Ethnopharmacol 2026: Decoctul Buyang Huanwu (MTC) atenueaza imbatranirea vasculara prin inhibarea axei NETs-HMGB1-TLR4-p38 MAPK. Reduce NETs (citrulina-H3), HMGB1 extracelular, IL-6, IL-1b, senescenta celulara. Rigidi…
8
mai
2026
Circ Res Studiu experimental Cross-sect.
👤 Wang H, Chen Y, Wang T, Ye X, Zhang X et al. | PMID: 41948821
Circ Res 2026: piRNA EPPIR (piR-mmu-57256903) din EV-uri cardiomiocitare post-exercitiu — cardioprotectie vs doxorubicina (DCT). EPPIR scazut in CMD si DCT. Mecanism: axa KDM6B-H3K27me3-Dtna (integritate sarcolema) + su…
8
mai
2026
Circ Res Studiu experimental Cross-sect.
👤 Xue M, Liang Y, Yuan Z, Liu X, Chang L et al. | PMID: 41859798
Circ Res 2026: Buzunar criptic in RhoA-GDP identificat prin analiza structurala. AH001 (produs natural) se leaga la buzunar, stabilizeaza RhoA-RhoGDIa (stare inactiva), inhiba MRTFA, reduce fibroza+hipertrofie in modele…
8
mai
2026
JCI Insight Studiu experimental Cross-sect.
👤 Kaur D, Chakrabarty S, Witzler C, Wang H, Wang M … | PMID: 41842964
JCI Insight 2026: TMPRSS2 epitelial intestinal activeaza PAR2 → creste secretia GIP postprandial si atenueaza axa ghrelin-GLP-1 in obezitate. KO TMPRSS2 sau inhibare farmacologica: restaureaza GLP-1 si efecte anti-diabe…
6
mai
2026
Cell Studiu experimental Cross-sect.
👤 Fournier M, Vanderkerken M, Dorgham K, Bastard P,… | PMID: 42097138
Cell 2026: AAN-I-IFN in COVID-19 sever — raspuns B celular preexistent infecției, derivat din centri germinativi, cu hipermutații somatice extinse (afinitate crescuta). Indistinct de defecte toleranta T genetice. Crista…
4
mai
2026
J Exp Med Studiu experimental Cross-sect.
👤 Li L, Castro M, Hongo H, Ren J, Shenkar R et al. | PMID: 41891922
J Exp Med 2026: CCM (malformatie cavernoasa cerebrala) — MEKK3-KLF2/4 induce expresia TIE2 (nu VEGFR2). Fosfo-TIE2 crescut in leziunile CCM umane si murine. Blocaj genetic/farmacologic TIE2: previne aproape complet CCM …
4
mai
2026
JACC Basic Transl Sci Studiu experimental Cross-sect.
👤 Condor Capcha JM, Robleto E, Martinez Naya N, Nie… | PMID: 42090756
JACC Basic Transl Sci 2026: Model murini miocardita COVID-19 (AAV9-cTnT-hLDLR + SARS-CoV-2 chimeric) — 100% penetranta, macrofage, necroza, piroptoza (gasdermin-D). Noua: interactiune LDLR (CR2-CR5)-osteopontina → recru…
3
mai
2026
Bioinformatics Studiu experimental Cross-sect.
👤 Zhou W, Jin C, Yao Z, Muthu SAMS, Chan YE et al. | PMID: 41719195
Bioinformatics 2026: Cadru de analiza federata cu criptare homorfica (PPFA) — calcul statistic distribuit pe date criptate fara transfer date brute. Validare: scoruri de risc poligenic si meta-analize pe 2 cohorte reale…
28
apr
2026
Circulation Studiu experimental Cross-sect.
👤 Zhu K, Guo J, Liu Y, Li J, Wang X et al. | PMID: 41797698
Circulation 2026: TRIM28 protejeaza impotriva feroptozei miocardice in I/R. Mecanism: TRIM28 = E3 ubiquitin-ligaza care ubiquitineaza IRP2 la K877 (K48-linked) → degradare IRP2 → reducere TFR1 → captare fier scazuta → m…